ESC 365 - Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: prevalence, correlates and prognostic impact (from the CORONOR study)

ESC Premium Access

Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: prevalence, correlates and prognostic impact (from the CORONOR study)

Session: Poster session 6 - Adjunctive medical therapy in coronary artery disease

Topic: Adjunctive medical therapy

Speaker: Professor G. Lemesle (Lille, FR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Gilles Lemesle

Lille University Hospital, Lille (France)

1 presentation

0 follower

26 more presentations in this session

Effects of statin therapy on plasma proprotein convertase subtilisin/kexin type 9 and sortilin levels in statin-naive patients with coronary artery disease

Speaker: Doctor T. Nozue (Yokohama, JP)

Is routine combination of renin-angiotensin system blocker and beta blocker beneficial in low-risk myocardial infarction patients?

Renalguard to prevent acute kidney injury in high risk patients undergoing coronary interventions

Speaker: Doctor V. Gritti (Cinisello Balsamo, IT)

Benefit of early statin initiation within 48 hours after admission in patients with acute myocardial infarction

Speaker: Associate Professor M. Kim (Gwangju, KR)

Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (<70mg/dl): data from CPACS studies

Speaker: Doctor Y. Sun (Beijing, CN)

Access the full session

Poster session 6 - Adjunctive medical therapy in coronary artery disease

Speakers: Professor G. Lemesle, Doctor T. Nozue, Doctor V. Gritti, Associate Professor M. Kim, Doctor Y. Sun

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources